Literature DB >> 8203462

Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.

I J Su1, R L Chen, D T Lin, K S Lin, C C Chen.   

Abstract

We have reported the prevalence of a fulminant hemophagocytic syndrome (HS) in previously healthy young children in Taiwan, most of which probably represent a lethal form of primary or active Epstein-Barr virus (EBV) infection. To further confirm their EBV association, in situ EBV hybridization (ISH) was performed on tissue biopsies from 15 pediatric HS patients (median age, 3 years and 4 months) using digoxigenin-labeled RNA probes EBER1. Double labeling immunostaining and ISH was then performed to define the immunophenotype of the lymphoid cells containing the EBV transcripts. Among the 13 patients who had serological evidence of acute or active EBV infection, 9 had demonstrable EBER1 transcripts in bone marrow, liver, and/or skin biopsies. EBER1-specific signal was not detectable in the two specimens from EBV-seronegative patients. The distribution of EBV-containing cells could be extensive or scattered. To our surprise, the EBER1 transcripts existed exclusively in T lymphoid cells in all nine cases examined rather than in B cells as previously believed in infectious mononucleosis. Considering the young affected age of the HS patients and the serological response to EBV, we suggest that EBV can infect T cells in primary EBV infection and the proliferation of these EBV-infected T cells may be responsible for the ominous outcome in childhood HS patients in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203462      PMCID: PMC1887465     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome.

Authors:  E C Mroczek; D D Weisenburger; H L Grierson; R Markin; D T Purtilo
Journal:  Arch Pathol Lab Med       Date:  1987-06       Impact factor: 5.534

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Age distribution of Epstein-Barr virus, cytomegalovirus and rubella virus antibodies.

Authors:  K H Lin; C H Chiang; C S Yang
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1987-12

4.  Virus-associated hemophagocytic syndrome due to Epstein-Barr virus.

Authors:  R P Reisman; M A Greco
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

5.  Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies.

Authors:  J L Sullivan; B A Woda; H G Herrod; G Koh; F P Rivara; C Mulder
Journal:  Blood       Date:  1985-05       Impact factor: 22.113

6.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

7.  Histiocytic medullary reticulosis associated with acute Epstein-Barr (EB) virus infection.

Authors:  R A Cohen; J J Hutter; M A Boxer; D S Goldman
Journal:  Am J Pediatr Hematol Oncol       Date:  1980

8.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

Authors:  J F Jones; S Shurin; C Abramowsky; R R Tubbs; C G Sciotto; R Wahl; J Sands; D Gottman; B Z Katz; J Sklar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

9.  Histiocytic medullary reticulosis following acute lymphoblastic leukemia.

Authors:  C M Starkie; M W Kenny; J R Mann; A H Cameron; F G Hill
Journal:  Cancer       Date:  1981-02-01       Impact factor: 6.860

10.  Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma.

Authors:  A L Cheng; I J Su; Y C Chen; W C Uen; C H Wang
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

View more
  22 in total

1.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.

Authors:  Huai-Chia Chuang; Jong-Ding Lay; Shuang-En Chuang; Wen-Chuan Hsieh; Yao Chang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

3.  Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Authors:  Sebastian Fernandez-Pol; Oscar Silva; Yasodha Natkunam
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

4.  Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.

Authors:  Guoshu Chen; Li Chen; Xiaohua Qin; Zhuoya Huang; Xiaoling Xie; Guowei Li; Bing Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 6.  The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Authors:  Megan C Smith; Daniel N Cohen; Bruce Greig; Ashwini Yenamandra; Cindy Vnencak-Jones; Mary Ann Thompson; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

7.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

8.  Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.

Authors:  Ren-Ching Wang; Sheng-Tsung Chang; Yen-Chuan Hsieh; Wan-Ting Huang; Jeng-Dong Hsu; Chih-En Tseng; Ming-Chung Wang; Wei-Shou Hwang; John Wang; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  Wen-Chuan Hsieh; Yao Chang; Mei-Chi Hsu; Bau-Shin Lan; Guan-Chung Hsiao; Huai-Chia Chuang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

10.  Severe chronic active EBV infection in an adult patient: case report.

Authors:  Sang-Yoon Ha; Chul-Won Chung; Young H Ko
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.